Landscape of potentially targetable receptor tyrosine kinase fusions in diverse cancers by DNA-based profiling.

NPJ Precis Oncol · 2022 · PMC9652465 · PMID 36369474

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

An increasing trend of RTK fusions following targeted therapies was also observed (Supplementary Fig. 12B ), which likely reflects clonal evolution imposed by drug selection.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.